Carthera is a clinical-stage medtech company that develops innovative medical devices using ultrasound to treat a wide range of severe brain pathologies. The company is in clinical evaluation. Its core product line focuses on ultrasound-based therapeutic devices for neurological conditions. Carthera operates in the health, MedTech and hardware sectors and follows a B2B strategy. Founders are Murielle Lemoine and Alexandre Carpentier. Investors named in the article include Panakes Partners, Turenne Capital and the European Innovation Council.

Total raised

$41M

Funding rounds

1

Latest round

Series B

Latest activity

Jul 2023